LANDAUER, INC. (NYSE:LDR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 26, 2017, Stephen C. Mitchell provided notice to the Board of Directors (the “Board”) of Landauer, Inc. (the “Company”) that he intends to retire from the Board, effective April 30, 2017. Mr. Mitchell expressed no disagreement with the Company over any of its operations, policies or practices.
About LANDAUER, INC. (NYSE:LDR)
Landauer, Inc. is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products. The Company provides radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries. Medical physics services are provided through the Company’s Landauer Medical Physics (LMP) division. The Company uses LMP as a platform to expand into the medical physics services market, serving domestic hospitals, radiation therapy centers and imaging centers. The Company’s Medical Products segment provides medical consumable accessories used in radiology, radiation therapy and image guided surgery procedures. LANDAUER, INC. (NYSE:LDR) Recent Trading Information
LANDAUER, INC. (NYSE:LDR) closed its last trading session down -0.05 at 52.95 with 15,866 shares trading hands.
